Tumors derived from individuals with hereditary nonpolyposis colorectal cancer syndrome frequently demonstrate mutations in both alleles of hMSH2, a key gene in DNA mismatch repair (MMR). Sporadic tumors also frequently exhibit MMR de®ciency. In keeping with the role of MMR in the maintenance of genome integrity, mice de®cient in MSH2 via gene targeting demonstrate a high incidence of thymic lymphomas and small intestinal adenocarcinomas. To investigate the eects of MSH2 de®ciency in normal tissues, mice containing a retrievable transgenic lacI reporter gene for mutation detection were crossed with MSH2 7/7 mice. Mice homozygous for MSH2 de®ciency revealed 4.8, 11.0 and 15.2-fold elevations in spontaneous mutation frequency in DNA obtained from brain, small intestine, and thymus, respectively, as compared to heterozygous or wild-type mice. Mutations most frequently recovered from MSH2 7/7 mice were single base substitutions (77%), particularly base transitions (64%). Frameshifts occurred less frequently (19%) and fell within very short (3 ± 5 bp) mononucleotide runs. Thus the number of key growth control genes potentially impacted by MMR de®ciency extends beyond those containing repetitive sequences. These results highlight the capacity for MSH2 de®ciency to serve as a potent driving force during the multi-step evolution of tumors.
Introduction
In Escherichia coli, the methyl-directed mutS, mutL, mutH dependent mismatch repair (MMR) pathway is responsible for the correction of single base mispairs and small insertion mispairs generated by misincorporations during DNA synthesis, from chemical damage to DNA, and during recombination events (Modrich, 1991) . A similar, although more complex, mismatch repair system also exists in eukaryotes. Indeed, six mammalian and ten yeast homologs of the bacterial mismatch repair genes have recently been identi®ed (Kolodner, 1996; Modrich and Lahue, 1996) .
In yeast, for example, the MutS homolog MSH2 forms a heterodimer with MSH6 or MSH3, providing the initial recognition of primarily single base mismatches, or 2 ± 4 bp loop mismatches, respectively (Johnson et al., 1996) . In humans, hMSH2 also forms a heterodimer with the MSH6 homolog p160/GTBP, resulting in the MutSa complex (Drummond et al., 1995; Palombo et al., 1995) . The identi®cation of a putative MSH3 homolog, MRP1 (Fujii and Shimada, 1989) , suggests an MSH2/MSH3 complex also functions in mammals.
Individuals with hereditary nonpolyposis colorectal cancer (HNPCC) carry germ-line mutations in one of several MMR genes, including hMSH2 (Fishel et al., 1993; Leach et al., 1993) . During tumorigenesis the wild-type allele can become mutated, apparently rendering the cell hypermutable as a result of the resultant MMR de®ciency. Such a`mutator' phenotype would then theoretically facilitate acquisition of new mutations within key growth control genes, thus accelerating the multi-step process that culminates in tumors, such as colorectal carcinoma (Fearon and Vogelstein, 1990) . The mutator phenotype observed within HNPCC cells is associated with instability of microsatellite repeats (Fishel et al., 1993; Leach et al., 1993; Nicolaides et al., 1994; Papadopoulos et al., 1994) , in keeping with the role of mismatch repair proteins in the correction of DNA polymerase slippage errors occurring at such sites. There is evidence also, of a broader role for mismatch repair proteins in processes such as transcription coupled repair, DNA recombination, and cell cycle DNA damage control (Hawn et al., 1995; Duckett et al., 1996; Worth et al., 1994) . Thus, the identi®cation of mutation types other than microsatellite instability in mismatch repair de®cient states can provide insights into the functions of speci®c MMR components.
Transgenic mutation-detection systems have proven invaluable in the assessment of mutation frequency and spectrum in tissues from intact animals (Mirsalis et al., 1995; Glazer et al., 1989) . These systems often employ chromosomally-integrated`neutral' mutation-detection target genes, such as the bacterial lacI, lacZ, and supF genes (Mirsalis et al., 1995; Glazer et al., 1989) . Such reporter genes carried within bacteriophage shuttlevectors or plasmid-based vectors enable the ecient recovery of mutants, so that in addition to yielding information about tissue-speci®c mutation frequencies, the mutation spectrum is also obtained through DNA sequence analysis (Mirsalis et al., 1995) .
To investigate the consequences of MSH2 de®ciency on the tissue-speci®c spontaneous mutation frequency and spectrum, a transgenic lacI-bearing lambda shuttle phage line (BC-1) developed for mutation detection (Andrew et al., 1996) was crossed with MSH2 +/7 mice that were generated by gene targeting technology (Reitmair et al., 1995) . MSH2 7/7 mice, although viable and fertile, develop lymphoid tumors, predominantly thymic lymphomas, with high frequency (Reitmair et al., 1995; de Wind et al., 1995) . They also develop tumors of the small intestine in the form of adenomas and subsequently adenocarcinomas (Reitmair et al., 1996) , thus strengthening the link between MMR de®ciency and oncogenesis.
Results
Elevated spontaneous mutation frequency in MSH2 heterozygotes, three BC-1/ MSH2 7/7 homozygotes and three BC-1 controls (MSH2 +/+ ) were analysed at 3 weeks of age using the methods of Kohler et al., 1990 Kohler et al., , 1991 . Mutation frequencies were determined for three dierent tissues in each animal: small intestine and thymus, the source of most of the tumors in the MSH2 7/7 mice; and brain, due to its relatively low mitotic activity at this age and also selected as a tissue not prone to tumor development in these mice (Table 1) . Mutation frequencies for MSH2 heterozygotes were similar to those of controls, suggesting that heterozygosity for an MMR mutation fails to signi®cantly handicap MMR under normal conditions. The mutation frequencies in homozygotes, however, were elevated in all three tissues evaluated (Table 1) . Mutation frequencies in brain were increased (4.8-fold) as compared to controls, although not to the extent seen in small intestine and thymus, where the increases were 11.0-fold and 15.2-fold, respectively. If the higher mutation frequencies seen in small intestine and thymus were re¯ective of the proliferating cell populations in these tissues, then the small intestine mutation frequencies observed, for example, likely represent an underestimate of gut epithelial cell frequencies, as whole small intestine (including smooth muscle) was included in the analysis.
Analysis of tissue-speci®c mutational spectra
A selection of lacI mutants was chosen at random from each of the three tissues of MSH2 7/7 and control animals for DNA sequencing (Table 2) . Recurrent mutations derived from the same tissue of a single animal could represent multiple independent events or may be the result of clonal expansion that occurred early within that particular tissue. Therefore, the number of mutations sequenced was corrected to report independent mutational events ( Mutation analysis of MSH2 ±/± mice SE Andrew et al When sequencing data was analysed conservatively by correcting for possible clonality, and when all the spontaneous control mutations were combined, transitions were most frequently observed (63.0%), followed by transversions (26.1%), deletions (6.5%) and frameshifts (4.3%) (Figure 1 ) consistent with our previous observations in non-DNA repair de®cient hosts (Andrew et al., 1996) . Analysis of the total number of MSH2 7/7 mutations revealed that transitions again represented approximately the same fraction of total mutations (64.2%), while transversions had decreased (13.2%), and, as expected, frameshifts had increased (18.9%) (Figure 1 ). The total number of transitions, transversions, frameshifts and deletions sequenced from MSH2 7/7 animals (all tissues combined) is signi®cantly dierent compared to the proportion of transitions, transversions, frameshifts and deletions sequenced from control animals when assessed using Chi square analysis (P=0.04). Interestingly, the only MSH2 7/7 deletion mutation observed was a 2 bp deletion that fell within a 6 bp dinucleotide repeat. The percentage of G:C to A:T transitions at CpG sites was similar in control and MSH2 7/7 mice (39.1% and 32.1% of mutations respectively) (Figure 1 ). The proportion of transitions, transversions and frameshifts in MSH2 7/7 mice varied somewhat from tissue to tissue (Table 2) . Thus, for example, frameshifts were more prevalent in lacI mutants recovered from brain DNA (27.3%) than in those from thymic DNA (3.8%), however, the number of mutants in each class of mutation is too small to make any tissue-speci®c conclusions.
The positions of mutations within the lacI gene for control, and MSH2 7/7 mice, corrected for possible clonality, are shown in Figure 2a and b, respectively.
Control and MSH2
7/7 animals shared mutations at twelve positions, with multiple mutations at some sites, as seen at positions 93, 180, and 270. Twenty-®ve sites were unique to lacI genes obtained from the control mice, while twenty-eight sites were unique to MSH2 7/7 mice.
Frameshift mutations were not observed at all mononucleotide repeats in MSH2 7/7 animals. For example, the run of ®ve adenine residues at position 135 ± 139, but not those at 1006 ± 1010, was frequently mutated. This might be attributable to the ®nding that mutations in the amino-terminal DNA binding domain are most likely to inactivate the lacI repressor (Gu et al., 1994) . In keeping with this observation, the majority of mutants recovered were localized to this region of the lacI gene (Figure 2a and b) .
The mutational spectrum of the lacI genes recovered from the mice diered from the bacterial lacI spectrum (Schaaper et al., 1986) , indicating that the mutations described had been acquired within the murine host (Figure 1 ). Sectored plaques, arising from bacterial processing of DNA damage acquired within the murine host, were not included in the results. Importantly, control and MSH2 7/7 DNA yielded equal frequencies of sectored plaques, demonstrating that the elevated mutation frequency in MSH2 7/7 animals did not simply stem from unrepaired DNA damage within the rescued phage genomes.
Discussion
We have crossed a transgenic lacI-bearing lambda shuttle phage line (BC-1) with MSH2 7/7 mice to investigate changes in spontaneous mutations arising as a consequence of MSH2 de®ciency. The elevated mutation frequency in MSH2 7/7 mice (4.8 ± 15.2-fold) is consistent with the increase in mutation frequency observed in mutS Escherichia coli (Dohet et al., 1985; Schaaper and Dunn, 1987) and MSH2 de®cient Saccharomyces cerevisiae (Reenan and Kolodner, 1992; Strand et al., 1993) . High hprt gene mutation frequencies were also observed in murine MSH2 de®cient embryonic stem cells (de Wind et al., 1995) , and in human tumor cell lines with MMR de®ciencies (Kat et al., 1993; Bhattacharyya et al., 1994; Eshleman et al., 1995; Branch et al., 1995) . The variability in mutation frequency between tissues (Table 1) may have been re¯ective of the mitotic history of each of the tissues (thymus4small intestine4brain). However, testing of additional animals will be necessary to establish the validity of this observation.
The proportion of transitions, transversions, frameshifts and deletions from MSH2 7/7 mice (when mutations from all tissues were combined) was signi®cantly dierent from that of the control animals ( Figure 1 ). The lacI mutation spectrum in mutS E. coli was similarly characterized by a predominance of basepair substitutions over frameshift mutations (Schaaper and Dunn, 1987; Cox, 1976; Leong et al., 1986) . In contrast to one study where only 37% of mutations were C to T transitions (Schaaper and Dunn, 1987) , we saw such changes at a frequency of 45.3%, with 70.8% occurring at CpG sites. This was in keeping with CpG dinucleotides being an important source of spontaneous mutations in mammals, due to G:T mismatch formation following deamination of 5-methyl cytosine residues (Cooper and Youssou®an, 1988) . In keeping with this, it is likely that the transgene array is methylated at many of the 95 CpG dinucleotides in each lacI gene.
The repeated isolation of speci®c lacI gene mutations from MSH2 de®cient mice was likely due either to clonal expansion of one particular mutant, or to the existence of mutational`hotspots' in the lacI gene. The ®nding of identical mutations in multiple tissues and in dierent animals, however, suggested the presence of hotspots. The two need not necessarily be mutually exclusive: for example, although position Figure 1 LacI gene mutation spectrum. LacI gene mutation spectrum from the three tissues obtained from control and MSH2 7/7 homozygote mice, corrected for possible clonality
Mutation analysis of MSH2 ±/± mice SE Andrew et al 180 was found to be mutated in lacI genes from the thymus, brain and small intestine of three dierent animals, suggestive of a`hotspot', the ®nding of eight mutations at position 180 in DNA from one thymus implied that expansion of a thymocyte clone carrying the 180 mutation may have occurred. Of interest, recurrent lacI mutations were more frequent in DNA isolated from the MSH2 7/7 mice than from control animals, where 76.8% of MSH2 7/7 mutations were unique per tissue per animal, compared to 93.9% of control mutations when compared by Chi square analysis (P=0.0005). This supported the concept of mutational`hotspots' that might be speci®c to the MSH2 7/7 host.
Interestingly, the`hotspot' for frameshift mutations seen at lacI position 135 ± 139 in mutS de®cient bacteria (Schaaper and Dunn, 1987) , was also the most common frameshift site in MSH2 7/7 mice. This ®nding may be indicative of the similarities in both DNA polymerase ®delity and MMR across widely divergent species when presented with the same DNA target sequence. It was also consistent with this site being a mutational`hotspot'. While position 180 was a common site for transition mutations in the eukaryotic hosts, no changes were observed at this position in MutS de®cient bacteria (Schaaper and Dunn, 1987) . Alternatively, mutations at position 93, a minor hotspot' in bacteria, also occurred in the MSH2 7/7 a Mutation analysis of MSH2 ±/± mice SE Andrew et al mice. It is interesting to speculate that transition mutations at position 180 in the eukaryotic host likely resulted from unrepaired G:T mismatches generated by 5-methyl cytosine deamination, while mutations at position 93 in both eukaryotes and prokaryotes arose from DNA polymerase misincorporations.
The ®nding of unique mutation sites in the lacI genes of control as compared to the MSH2 7/7 mice was consistent with the actions of at least two independent processes in determining the mutational spectrum: the ®rst being the frequency of sequencedependent DNA polymerase errors, and the second re¯ecting the capacity of speci®c mismatches, within a given sequence context, to serve as substrates for MSH2-initiated recognition and repair.
The predominance of point mutations within lacI genes obtained from MSH2 de®cient mice, suggested that single-base mispairs (especially transitions), and not frameshifts were the most common DNA polymerase errors in such genes and that such errors are normally eciently repaired. This was in keeping with evidence from bacteria indicating a preference of the proofreading activity of pol III for transversions over transitions (Sloane et al., 1988) . The occurrence of 7/7 mice. Deletions are underlined. The number of mutations was corrected to report unique mutation sites per tissue per animal Mutation analysis of MSH2 ±/± mice SE Andrew et al slippage of one nucleotide (71 more frequently than +1) at homonucleotide stretches was the second most common class of mutation within the lacI gene of MMR de®cient animals. Interestingly, all but one of the frameshifts occurred at a repeat of three or more mononucleotides, with 5/11 (48%) occurring at a 5 adenine repeat.
The ®nding of frameshifts at a 3 mononucleotide repeat suggests that many genomic sites, in addition to those containing highly repetitive dinucleotide tracts, are at risk of frameshift mutations in MSH2 de®ciency. This observation, along with the ®nding of an elevated frequency of transitions indicated that all genes are potential targets for mutation in MSH2 de®ciency. Tumor development in HNPCC appears to involve the accumulation of multiple mutations in oncogenes and tumor suppressor genes (Fearon and Jones, 1992) . Targets for mutation thus include tumor suppressor genes such as p53 and APC. Interestingly, the majority of somatic mutations in the p53 gene of colorectal cancers are base substitutions (Beroud et al., 1996) , with over 50% of these being transitions at CpG dinucleotides (Fearon and Jones, 1992) . Thus, in addition to mutations in genes containing mononucleotide repeats, such as that encoding TGF-b receptor , MMR de®ciency potentially increases the frequency of damage to key growth control genes typically inactivated by point mutations. Indeed, in HNPCC tumors, mutations within APC and p53 genes are 40% frameshifts and 60% point mutations (Lazar et al., 1994) ; 70% of APC mutations in another study are frameshifts, with the remainder being point mutations (Huang et al., 1996) .
Recently, PMS2 de®cient mice carrying a supF reporter gene were analysed (Narayanan et al., 1997) . The mutation frequency of supF/PMS2 7/7 mice was approximately 25 ± 100-fold higher than normal, substantially higher than the lacI/MSH2 7/7 mutation frequency. The mutants recovered from the PMS2 7/7 also diered from that of the MSH2 7/7 mice, revealing a higher proportion of frameshift mutations and fewer base substitutions, in keeping with the repetitive sequences within the supF target genes employed. As MSH2 and PMS2 operate within the same MMR pathway, the observed dierences highlight the critical importance of the target gene in determining both mutation frequency and spectrum. Alternatively, the dierences could, in part, be due to MSH2-speci®c functions not involving MutL homologs. Complementary crosses of mice de®cient in speci®c MMR components and transgenic reporter gene strains will be necessary to clarify these issues further.
Materials and methods

Transgenic mice and genotype testing MSH2
+/7 heterozygotes developed by gene targeting (Reitmair et al., 1995) were bred with BC-1 transgenic mice to generate BC-1/MSH2 7/7 , BC-1/MSH2 +/7 and BC-1/MSH2 +/+ mice. Tissue samples for testing consisted of tail clips obtained from anesthetized mice. Tail samples were digested in 1.2 mg/ml Proteinase K, 50 mM Tris-HCl pH 8.0, 10 mM EDTA, 0.1% SDS, and 100 mM NaCl. Animals carrying the lacI transgene and MSH2 wild-type, heterozygotes or homozygous for the`null' allele were identi®ed using a previously described PCR assay (Andrew et al., 1996; Reitmair et al., 1995) . Two females and one male animal, between 19 and 27 days of age were assessed for each of the MSH2 +/+ , MSH2 +/7 , and MSH2 7/7
genotypes.
Determination of lacI gene mutation frequency and spectrum
Tissue isolation and transgenic lambda phage rescue were carried out as described (Kohler et al., 1990 (Kohler et al., , 1991 . Brie¯y, phage genomes within high molecular weight BC-1 transgenic mouse DNA were excised and packaged using the highly ecient phage packaging extract, Transpack (Stratagene). Rescued phage were then plated in the presence of X-gal on an SCS-8 (Stratagene) bacterial cell lawn. LacI mutant frequency was established by determining the ratio of mutant (blue) to non-mutant (colorless) plaques. To obtain accurate mutant frequencies, between 200 000 and 300 000 plaque forming units (pfu) were plated per tissue per animal. Phage with lacI mutations were veri®ed as previously described (Andrew et al., 1996) . Following phage rescue and the isolation of single mutant clones, lacI genes were ampli®ed by PCR of phage templates. Templates were then directly sequenced using primers spanning the lacI gene (Andrew et al., 1996) and an ABI 388 sequencer (Applied Biosystems).
